0001104659-22-072185.txt : 20220617 0001104659-22-072185.hdr.sgml : 20220617 20220617082706 ACCESSION NUMBER: 0001104659-22-072185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAREKH RAJESH B CENTRAL INDEX KEY: 0001429930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 221022461 MAIL ADDRESS: STREET 1: ALCHESTER HOUSE, LANGFORD LANE STREET 2: NORTH WENDLEBURY CITY: BICHESTER STATE: X0 ZIP: OX6 ONS FORMER NAME: FORMER CONFORMED NAME: PAREKH RAJESH R DATE OF NAME CHANGE: 20080317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001035354 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841368850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY STREET 2: SUITE 130 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 781-577-5300 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY STREET 2: SUITE 130 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Sevion Therapeutics, Inc. DATE OF NAME CHANGE: 20140930 FORMER COMPANY: FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC DATE OF NAME CHANGE: 19991006 FORMER COMPANY: FORMER CONFORMED NAME: NAVA LEISURE USA INC DATE OF NAME CHANGE: 19970310 4 1 tm2218714-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-15 0 0001035354 Eloxx Pharmaceuticals, Inc. ELOX 0001429930 PAREKH RAJESH B C/O ELOXX PHARMACEUTICALS, INC 480 ARSENAL WAY, SUITE 130 WATERTOWN MA 02472 1 0 0 0 Stock Options (Right to Buy) 0.26 2022-06-15 4 A 0 20000 0 A 2032-06-15 Common Stock 20000 20000 D The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter. The Reporting Person will assign the economic interests of this grant to Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP. /s/ Sumit Aggarwal, Attorney-in-Fact for Rajesh B. Parekh 2022-06-16